Edition:
India

Horizon Therapeutics Initiates Trial Evaluating Krystexxa In Combination With Methotrexate


Thursday, 20 Jun 2019 

June 20 (Reuters) - Horizon Therapeutics PLC ::HORIZON THERAPEUTICS PLC INITIATES MIRROR RANDOMIZED CONTROLLED TRIAL EVALUATING KRYSTEXXA® (PEGLOTICASE INJECTION) IN COMBINATION WITH METHOTREXATE TO INCREASE RESPONSE RATES AND DURATION OF THERAPY. 

Company Quote

23.98
-0.12 -0.50%
1:30am IST